Rare disease drugs

These companies develop and sell drugs for rare conditions, mostly inherited ones, as their main business.
−6.2%
over 3 months · S&P 500 −2.1%

Key indicators

Health
50 / 100
Fragile
Solid
Price
P/E 23
Cheap
Expensive
Up over 1 year
33 of 63
Wallets over 90 days
1 / 2 buys / sells
Buys
Sells
Health and price: against the other tags.

The 65 companies

VRTX
+4.5%
UTHR
+16.3%
ALNY
−26.5%
Others
Size: weight in the tag. Color: move over the period.
See all companies
V
Vertex Pharmaceuticals
VRTX
37.7%
+4.5%
I
Insmed
INSM
7.3%
−5.6%
U
United Therapeutics
UTHR
7.0%
+16.3%
A
Alnylam Pharmaceuticals
ALNY
6.1%
−26.5%
N
Neurocrine Biosciences
NBIX
4.8%
+8.4%
B
BridgeBio Pharma
BBIO
4.3%
−2.0%
B
BioMarin Pharmaceutical
BMRN
3.1%
−14.1%
K
Krystal Biotech
KRYS
2.5%
−9.1%
R
Rhythm Pharmaceuticals
RYTM
2.2%
−0.4%
M
Mirum Pharmaceuticals
MIRM
1.7%
−5.8%
S
Scholar Rock Holding
SRRK
1.5%
−17.0%
P
PTC Therapeutics
PTCT
1.5%
−12.9%
C
Cogent Biosciences
COGT
1.4%
−24.6%
L
Liquidia
LQDA
1.4%
−26.1%
I
Ionis Pharmaceuticals
IONS
1.3%
−50.4%
T
Travere Therapeutics
TVTX
1.3%
−20.3%
A
Amylyx Pharmaceuticals
AMLX
1.1%
+41.3%
I
Disc Medicine
IRON
1.1%
−0.1%
D
Dyne Therapeutics
DYN
0.9%
−34.4%
A
ACADIA Pharmaceuticals
ACAD
0.9%
−35.4%
D
Denali Therapeutics
DNLI
0.9%
−23.0%
P
Palvella Therapeutics
PVLA
0.7%
−0.7%
B
Beam Therapeutics
BEAM
0.7%
−15.8%
M
Maze Therapeutics
MAZE
0.6%
+22.8%
S
Sarepta Therapeutics
SRPT
0.5%
−11.6%
X
Xeris Biopharma
XERS
0.5%
+95.5%
B
BioCryst Pharmaceuticals
BCRX
0.5%
−23.4%
A
Agios Pharmaceuticals
AGIO
0.5%
−6.1%
E
Eton Pharmaceuticals
ETON
0.5%
+3.6%
C
Hemab Therapeutics
COAG
0.5%
−23.8%
S
Stoke Therapeutics
STOK
0.5%
−17.0%
P
Precigen
PGEN
0.5%
−30.7%
R
Ultragenyx Pharmaceutical
RARE
0.5%
−38.5%
T
Taysha Gene Therapies
TSHA
0.4%
−34.0%
A
Avalyn Pharma
AVLN
0.4%
−20.8%
S
Savara
SVRA
0.3%
−13.6%
M
MeiraGTx Holdings
MGTX
0.3%
−33.3%
I
Immix Biopharma
IMMX
0.2%
−30.9%
Z
Zevra Therapeutics
ZVRA
0.2%
−21.2%
S
Solid Biosciences
SLDB
0.2%
−24.8%
D
Design Therapeutics
DSGN
0.2%
−30.7%
C
Capricor Therapeutics
CAPR
0.2%
+27.9%
N
Neurogene
NGNE
0.1%
−34.8%
M
Monopar Therapeutics
MNPR
0.1%
−38.2%
T
Tectonic Therapeutic
TECX
0.1%
−37.5%
R
Rezolute
RZLT
0.1%
−21.9%
O
Ocugen
OCGN
<0.1%
−39.8%
F
Fulcrum Therapeutics
FULC
<0.1%
−1.8%
L
Larimar Therapeutics
LRMR
<0.1%
−30.1%
R
Rocket Pharmaceuticals
RCKT
<0.1%
−32.4%
L
Lexeo Therapeutics
LXEO
<0.1%
−42.4%
A
Arcturus Therapeutics
ARCT
<0.1%
+2.7%
T
Entrada Therapeutics
TRDA
<0.1%
−30.5%
K
Korro Bio
KRRO
<0.1%
+3.6%
P
PepGen
PEPG
<0.1%
+43.4%
S
Sionna Therapeutics
SION
<0.1%
−43.7%
I
Inovio Pharmaceuticals
INO
<0.1%
+24.3%
A
Abeona Therapeutics
ABEO
<0.1%
−59.3%
S
Spruce Biosciences
SPRB
<0.1%
−18.2%
A
Aardvark Therapeutics
AARD
<0.1%
−80.3%
A
Ascendis Pharma
ASND
+11.3%
J
Jazz Pharmaceuticals
JAZZ
−2.7%
P
Pharvaris
PHVS
−5.5%
Q
uniQure
QURE
−50.4%
S
Sol-Gel Technologies
SLGL
−33.6%